Possible mechanism for improving the endogenous immune system through the blockade of peripheral μ-opioid receptors by treatment with naldemedine

[1]  Zhirong Sun,et al.  Increased mu-opioid receptor expression is associated with reduced disease-free and overall survival in laryngeal squamous cell carcinoma. , 2020, British journal of anaesthesia.

[2]  Chunhua Chen,et al.  Toll-Like Receptor 4 (TLR4)/Opioid Receptor Pathway Crosstalk and Impact on Opioid Analgesia, Immune Function, and Gastrointestinal Motility , 2020, Frontiers in Immunology.

[3]  H. Machelska,et al.  Opioid Receptors in Immune and Glial Cells—Implications for Pain Control , 2020, Frontiers in Immunology.

[4]  H. Hasegawa,et al.  Minimal contribution of P-gp on the low brain distribution of naldemedine, a peripherally acting μ-opioid receptor antagonist. , 2019, Drug metabolism and pharmacokinetics.

[5]  A. Nakamura,et al.  Pharmacologic effects of naldemedine, a peripherally acting μ‐opioid receptor antagonist, in in vitro and in vivo models of opioid‐induced constipation , 2019, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[6]  H. Okano,et al.  Down-regulation of ghrelin receptors on dopaminergic neurons in the substantia nigra contributes to Parkinson’s disease-like motor dysfunction , 2018, Molecular Brain.

[7]  A. Zarbock,et al.  Perioperative Inflammation and Its Modulation by Anesthetics , 2017, Anesthesia and analgesia.

[8]  J. Cavaillon,et al.  Toll-like receptors expression and interferon- (cid:13) production by NK cells in human sepsis. , 2018 .

[9]  F. Janku,et al.  Treatment with methylnaltrexone is associated with increased survival in patients with advanced cancer. , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

[10]  K. Palczewski,et al.  Designing Safer Analgesics via μ-Opioid Receptor Pathways. , 2017, Trends in pharmacological sciences.

[11]  B. Barres,et al.  Loss of μ-opioid receptor signaling in nociceptors, and not spinal microglia, abrogates morphine tolerance without disrupting analgesic efficacy , 2016, Nature Medicine.

[12]  Y. Uezono,et al.  Characterization of methadone as a β-arrestin-biased μ-opioid receptor agonist , 2016, Molecular pain.

[13]  R. Al-Hasani,et al.  Pain and Poppies: The Good, the Bad, and the Ugly of Opioid Analgesics , 2015, The Journal of Neuroscience.

[14]  G. Becker,et al.  Emerging treatments in neurogastroenterology: a multidisciplinary working group consensus statement on opioid‐induced constipation , 2014, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[15]  L. Watkins,et al.  In vivo veritas: (+)-Naltrexone's actions define translational importance: A letter in response to Skolnick et al. 'Translational potential of naloxone and naltrexone as TLR4 antagonists'. , 2014, Trends in pharmacological sciences.

[16]  P. Greenberg,et al.  Tolerance and exhaustion: defining mechanisms of T cell dysfunction. , 2014, Trends in immunology.

[17]  M. Kuskowski,et al.  Opioid requirement, opioid receptor expression, and clinical outcomes in patients with advanced prostate cancer , 2013, Cancer.

[18]  T. Okazaki,et al.  A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical application , 2013, Nature Immunology.

[19]  Xinying Li,et al.  T Cell Ig Mucin-3 Promotes Homeostasis of Sepsis by Negatively Regulating the TLR Response , 2013, The Journal of Immunology.

[20]  J. Cavaillon,et al.  Toll-like receptors expression and interferon-γ production by NK cells in human sepsis , 2012, Critical Care.

[21]  Sulie L. Chang,et al.  Opioid receptor expression in human brain and peripheral tissues using absolute quantitative real-time RT-PCR. , 2012, Drug and alcohol dependence.

[22]  P. Sacerdote,et al.  Mu opioid receptor activation modulates Toll like receptor 4 in murine macrophages , 2012, Brain, Behavior, and Immunity.

[23]  Chin-Tu Chen,et al.  The Novel Role of the Mu Opioid Receptor in Lung Cancer Progression: A Laboratory Investigation , 2011, Anesthesia and analgesia.

[24]  Mark J. Smyth,et al.  Functional significance of the perforin/granzyme cell death pathway , 2002, Nature Reviews Immunology.